Kunjal Patel

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. doi request reprint Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study
    Kunjal Patel
    Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02115, USA
    Clin Infect Dis 46:507-15. 2008
  2. pmc The impact of HAART on cardiomyopathy among children and adolescents perinatally infected with HIV-1
    Kunjal Patel
    Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
    AIDS 26:2027-37. 2012
  3. pmc Long-term effects of highly active antiretroviral therapy on CD4+ cell evolution among children and adolescents infected with HIV: 5 years and counting
    Kunjal Patel
    Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02115, USA
    Clin Infect Dis 46:1751-60. 2008
  4. pmc Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents
    Kunjal Patel
    Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
    AIDS 23:1893-901. 2009
  5. pmc Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy
    Kunjal Patel
    Department of Epidemiology, Harvard School of Public Health, Boston Massachusetts 02115, USA
    J Infect Dis 201:1035-44. 2010
  6. pmc Aggregate risk of cardiovascular disease among adolescents perinatally infected with the human immunodeficiency virus
    Kunjal Patel
    Department of Epidemiology, Harvard School of Public Health, Boston, MA K P, G R S Center for Biostatistics in AIDS Research, Boston, MA K P, J W, D L J, G R S, P L W Department of Pediatrics, Wayne State University School of Medicine, Children s Hospital of Michigan, Detroit S E L Division of Pediatric Clinical Research and Division of Pediatric Infectious Disease and Immunology, Department of Pediatrics, University of Miami Miller School of Medicine, Miami, FL D C L, G B S, J D W, T L M Saban Research Institute of Children s Hospital Los Angeles, Keck School of Medicine of USC, Los Angeles, CA M E G Section of Pediatric Endocrinology and Diabetology, Department of Pediatrics, Indiana University School of Medicine, Indianapolis L A D M Department of Pediatrics, Tulane University Health Sciences Center, New Orleans, LA R B V D Maternal and Pediatric Infectious Disease Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD G K S Department of Pediatrics, Baylor College of Medicine, Texas Children s Hospital, Houston W T S Department of Pediatrics, Northwestern University Feinberg School of Medicine, Children s Memorial Hospital, Chicago, IL L Y Division of Cardiology, University of Maryland School of Medicine, Brazil
    Circulation 129:1204-12. 2014
  7. pmc Pubertal onset in children with perinatal HIV infection in the era of combination antiretroviral treatment
    Paige L Williams
    aCenter for Biostatistics in AIDS Research bDepartment of Biostatistics, Harvard School of Public Health, Boston, Massachusetts cDepartment of Pediatrics Infectious Diseases, University of Colorado School of Medicine and Children s Hospital Colorado, Aurora, Colorado dTulane University School of Medicine, New Orleans, Louisiana eEunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland fDepartment of Epidemiology, Harvard School of Public Health, Boston, Massachusetts gSection of Pediatric Endocrinology, Indiana University School of Medicine, Indianapolis, Indiana hDepartment of Pediatrics, University of Colorado School of Medicine, Denver, Colorado iNew York University School of Medicine, New York jDepartment of Pediatrics, New Jersey Medical School, Newark, New Jersey kSaban Research Institute, Children s Hospital Los Angeles, Los Angeles, California, USA
    AIDS 27:1959-70. 2013
  8. ncbi request reprint The Pediatric AIDS Severity Score (PASS): a multidimensional AIDS-severity adjustment for pediatric HIV infection
    George R Seage
    Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA
    J Acquir Immune Defic Syndr 43:603-10. 2006
  9. doi request reprint Growth at 2 Years of Age in HIV-exposed Uninfected Children in the United States by Trimester of Maternal Antiretroviral Initiation
    Denise L Jacobson
    From the Department of Pediatrics, Center for Biostatistics in AIDS Research, Harvard T H Chan School of Public Health, and Department of Epidemiology, Harvard T H Chan School of Public Health, Boston, Massachusetts Department of Pediatrics, The Saban Research Institute, Children s Hospital Los Angeles, Keck School of Medicine of USC, Los Angeles, California Maternal and Pediatric Infectious Disease MPID Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana Department of Pediatrics, University of Alabama School of Medicine, Birmingham, Alabama Department of Pediatrics, University of Florida, Jacksonville, Florida Department of Pediatrics, Drexel University College of Medicine, Philadelphia, Pennsylvania Department of Pediatrics, Children s Hospital Colorado, Denver, Colorado Department of Pediatrics, Tulane University School of Medicine, New Orleans, Louisiana Department of Pediatrics, University of Illinois at Chicago, Chicago, Illinois Department of Pediatrics, New York University Langone Medical Center, New York, New York and Division of Pediatric Clinical Research, Department of Pediatrics, Miller School of Medicine at the University of Miami, Miami, Florida
    Pediatr Infect Dis J 36:189-197. 2017
  10. pmc CD4+ and viral load outcomes of antiretroviral therapy switch strategies after virologic failure of combination antiretroviral therapy in perinatally HIV-infected youth in the United States
    Lee Fairlie
    aWits Reproductive Health and HIV Institute WRHI, University of the Witwatersrand, Johannesburg, South Africa bDepartment of Epidemiology, Center for Biostatistics in AIDS Research CBAR, Harvard School of Public Health, Boston, Massachusetts cTulane University School of Medicine, New Orleans, Louisiana dEunice Kennedy Shriver National Institute of Child Health and Human Development NICHD, National Institutes of Health, Bethesda, Maryland eHarvard MIT Division of Health Sciences and Technology, Boston, Massachusetts fJohns Hopkins University School of Medicine, Baltimore, Maryland gJacobi Medical Center Family Based Services, Albert Einstein College of Medicine, Bronx, New York, USA
    AIDS 29:2109-19. 2015

Detail Information

Publications20

  1. doi request reprint Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study
    Kunjal Patel
    Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02115, USA
    Clin Infect Dis 46:507-15. 2008
    ..Given that HIV infection is chronic and that exposure to HAART is likely to be life-long, there is a need to evaluate the long-term effect of HAART on survival in this population...
  2. pmc The impact of HAART on cardiomyopathy among children and adolescents perinatally infected with HIV-1
    Kunjal Patel
    Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
    AIDS 26:2027-37. 2012
    ..We evaluated the association of HAART and specific NRTIs associated with mitochondrial toxicity, on development of cardiomyopathy among perinatally HIV-infected children...
  3. pmc Long-term effects of highly active antiretroviral therapy on CD4+ cell evolution among children and adolescents infected with HIV: 5 years and counting
    Kunjal Patel
    Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02115, USA
    Clin Infect Dis 46:1751-60. 2008
    ....
  4. pmc Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents
    Kunjal Patel
    Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
    AIDS 23:1893-901. 2009
    ....
  5. pmc Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy
    Kunjal Patel
    Department of Epidemiology, Harvard School of Public Health, Boston Massachusetts 02115, USA
    J Infect Dis 201:1035-44. 2010
    ..Conflicting results have been reported among studies of protease inhibitor (PI) use during pregnancy and preterm birth. Uncontrolled confounding by indication may explain some of the differences among studies...
  6. pmc Aggregate risk of cardiovascular disease among adolescents perinatally infected with the human immunodeficiency virus
    Kunjal Patel
    Department of Epidemiology, Harvard School of Public Health, Boston, MA K P, G R S Center for Biostatistics in AIDS Research, Boston, MA K P, J W, D L J, G R S, P L W Department of Pediatrics, Wayne State University School of Medicine, Children s Hospital of Michigan, Detroit S E L Division of Pediatric Clinical Research and Division of Pediatric Infectious Disease and Immunology, Department of Pediatrics, University of Miami Miller School of Medicine, Miami, FL D C L, G B S, J D W, T L M Saban Research Institute of Children s Hospital Los Angeles, Keck School of Medicine of USC, Los Angeles, CA M E G Section of Pediatric Endocrinology and Diabetology, Department of Pediatrics, Indiana University School of Medicine, Indianapolis L A D M Department of Pediatrics, Tulane University Health Sciences Center, New Orleans, LA R B V D Maternal and Pediatric Infectious Disease Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD G K S Department of Pediatrics, Baylor College of Medicine, Texas Children s Hospital, Houston W T S Department of Pediatrics, Northwestern University Feinberg School of Medicine, Children s Memorial Hospital, Chicago, IL L Y Division of Cardiology, University of Maryland School of Medicine, Brazil
    Circulation 129:1204-12. 2014
    ....
  7. pmc Pubertal onset in children with perinatal HIV infection in the era of combination antiretroviral treatment
    Paige L Williams
    aCenter for Biostatistics in AIDS Research bDepartment of Biostatistics, Harvard School of Public Health, Boston, Massachusetts cDepartment of Pediatrics Infectious Diseases, University of Colorado School of Medicine and Children s Hospital Colorado, Aurora, Colorado dTulane University School of Medicine, New Orleans, Louisiana eEunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland fDepartment of Epidemiology, Harvard School of Public Health, Boston, Massachusetts gSection of Pediatric Endocrinology, Indiana University School of Medicine, Indianapolis, Indiana hDepartment of Pediatrics, University of Colorado School of Medicine, Denver, Colorado iNew York University School of Medicine, New York jDepartment of Pediatrics, New Jersey Medical School, Newark, New Jersey kSaban Research Institute, Children s Hospital Los Angeles, Los Angeles, California, USA
    AIDS 27:1959-70. 2013
    ..To evaluate associations of perinatal HIV infection, HIV disease severity, and combination antiretroviral treatment with age at pubertal onset...
  8. ncbi request reprint The Pediatric AIDS Severity Score (PASS): a multidimensional AIDS-severity adjustment for pediatric HIV infection
    George R Seage
    Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA
    J Acquir Immune Defic Syndr 43:603-10. 2006
    ..A severity staging system predictive of mortality for perinatally HIV-infected children is needed for clinical and research purposes...
  9. doi request reprint Growth at 2 Years of Age in HIV-exposed Uninfected Children in the United States by Trimester of Maternal Antiretroviral Initiation
    Denise L Jacobson
    From the Department of Pediatrics, Center for Biostatistics in AIDS Research, Harvard T H Chan School of Public Health, and Department of Epidemiology, Harvard T H Chan School of Public Health, Boston, Massachusetts Department of Pediatrics, The Saban Research Institute, Children s Hospital Los Angeles, Keck School of Medicine of USC, Los Angeles, California Maternal and Pediatric Infectious Disease MPID Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana Department of Pediatrics, University of Alabama School of Medicine, Birmingham, Alabama Department of Pediatrics, University of Florida, Jacksonville, Florida Department of Pediatrics, Drexel University College of Medicine, Philadelphia, Pennsylvania Department of Pediatrics, Children s Hospital Colorado, Denver, Colorado Department of Pediatrics, Tulane University School of Medicine, New Orleans, Louisiana Department of Pediatrics, University of Illinois at Chicago, Chicago, Illinois Department of Pediatrics, New York University Langone Medical Center, New York, New York and Division of Pediatric Clinical Research, Department of Pediatrics, Miller School of Medicine at the University of Miami, Miami, Florida
    Pediatr Infect Dis J 36:189-197. 2017
    ..Abnormal childhood growth may affect future health. Maternal tenofovir (TFV) use was associated with lower body length and head circumference at 1 year of age in HIV-exposed uninfected (HEU) US children...
  10. pmc CD4+ and viral load outcomes of antiretroviral therapy switch strategies after virologic failure of combination antiretroviral therapy in perinatally HIV-infected youth in the United States
    Lee Fairlie
    aWits Reproductive Health and HIV Institute WRHI, University of the Witwatersrand, Johannesburg, South Africa bDepartment of Epidemiology, Center for Biostatistics in AIDS Research CBAR, Harvard School of Public Health, Boston, Massachusetts cTulane University School of Medicine, New Orleans, Louisiana dEunice Kennedy Shriver National Institute of Child Health and Human Development NICHD, National Institutes of Health, Bethesda, Maryland eHarvard MIT Division of Health Sciences and Technology, Boston, Massachusetts fJohns Hopkins University School of Medicine, Baltimore, Maryland gJacobi Medical Center Family Based Services, Albert Einstein College of Medicine, Bronx, New York, USA
    AIDS 29:2109-19. 2015
    ..This study compared 12-month CD4 and viral load outcomes in HIV-infected children and adolescents with virological failure, managed with four treatment switch strategies...
  11. pmc Incomplete immune reconstitution despite virologic suppression in HIV-1 infected children and adolescents
    Paul Krogstad
    aDepartment of Pediatrics Infectious Diseases bDepartment of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California cDepartment of Epidemiology, Center for Biostatistics in AIDS Research CBAR, Harvard School of Public Health, Boston, Massachusetts dEunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland eUniversity of Colorado School of Medicine and Children s Hospital Colorado, Aurora, Colorado fDepartment of Pediatrics, Rutgers New Jersey Medical School, Newark, New Jersey gNew York University School of Medicine hAlbert Einstein College of Medicine, New York City, New York, USA iDepartment of Pediatrics, Federal University of Minas Gerais, Minas Gerais, Brazil jTulane University School of Medicine, New Orleans, Louisiana, USA
    AIDS 29:683-93. 2015
    ..The frequency, severity and significance of these discordant treatment responses remain unclear...
  12. pmc Atazanavir exposure in utero and neurodevelopment in infants: a comparative safety study
    Ellen C Caniglia
    aHarvard T H Chan School of Public Health, Boston, Massachusetts bDepartment of Psychiatry and Behavioral Sciences, University of Southern California Keck School of Medicine, Los Angeles, California cNational Institutes of Health, National Institute of Mental Health, Bethesda, Maryland dUniversity of Illinois at Chicago College of Medicine, Chicago, Illinois eTulane University School of Medicine, New Orleans, Louisiana fHarvard MIT Division of Health Sciences and Technology, Boston, Massachusetts, USA
    AIDS 30:1267-78. 2016
    ..To evaluate the safety of in-utero exposure to atazanavir and neurodevelopment in perinatally HIV-exposed but uninfected (PHEU) infants...
  13. pmc Complications and Route of Delivery in a Large Cohort Study of HIV-1-Infected Women-IMPAACT P1025
    Elizabeth G Livingston
    Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Duke University Medical Center, Durham, NC Center for Biostatistics in AIDS Research, Harvard T H Chan School of Public Health, Boston, MA Department of Epidemiology, Harvard T H Chan School of Public Health, Boston, MA Department of Obstetrics and Gynecology, Brigham and Women s Hospital, Harvard University School of Medicine, Boston, MA Department of Pediatrics, University of Miami Miller School of Medicine, Miami, FL and Department of Obstetrics and Gynecology, University of Southern California Keck School of Medicine, Los Angeles, CA
    J Acquir Immune Defic Syndr 73:74-82. 2016
    ..To investigate complications of cesarean section in a cohort of HIV-infected pregnant women...
  14. pmc Body fat distribution in perinatally HIV-infected and HIV-exposed but uninfected children in the era of highly active antiretroviral therapy: outcomes from the Pediatric HIV/AIDS Cohort Study
    Denise L Jacobson
    Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, MA, USA
    Am J Clin Nutr 94:1485-95. 2011
    ..Associations between abnormal body fat distribution and clinical variables are poorly understood in pediatric HIV disease...
  15. pmc Phenotypic Coreceptor Tropism in Perinatally HIV-infected Youth Failing Antiretroviral Therapy
    Allison L Agwu
    From the Division of Pediatric Infectious Diseases, Department of Pediatrics, Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland Center for Biostatistics in AIDS Research CBAR, Harvard School of Public Health, Boston, Massachusetts Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland Monogram Biosciences, South San Francisco, California Boston Children s Hospital and Harvard Medical School, Boston, Massachusetts Maternal and Pediatric Infectious Disease Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland and Section of Infectious Diseases, Department of Pediatrics, Tulane University School of Medicine, New Orleans, Los Angeles
    Pediatr Infect Dis J 35:777-81. 2016
    ..We characterized phenotypic coreceptor usage among PHIV children and youth with VF on antiretroviral treatment to identify predictors of CXCR4 (X4) tropism which preclude R5 antagonist use...
  16. pmc Elevated aspartate aminotransferase-to-platelet ratio index in perinatally HIV-infected children in the United States
    George K Siberry
    From the Maternal and Pediatric Infectious Disease Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD Department of Epidemiology and Center for Biostatistics in AIDS Research CBAR, Harvard School of Public Health, Boston, MA Department of Pediatrics, Federal University of Minas Gerais, Belo Horizonte, Brazil Children s Diagnostic and Treatment Center, Inc, Fort Lauderdale Department of Pediatrics, University of Florida, Jacksonville Department of Pediatrics, Division of Pediatric Clinical Research, Miller School of Medicine at the University of Miami, Miami, FL and Department of Pediatrics, Tulane University Health Sciences Center, New Orleans, LA
    Pediatr Infect Dis J 33:855-7. 2014
    ..2-2.2%) and >0.5 in 6.5% (95% CI, 4.3-9.4%); incidence on study was 0.5 (95% CI, 0.2-1.2) and 6.4 (95% CI, 4.8-8.3) per 100 person-years, respectively. Long-term liver outcomes after perinatal HIV infection warrant further study. ..
  17. pmc Infant growth outcomes after maternal tenofovir disoproxil fumarate use during pregnancy
    Carla E Ransom
    Department of Obstetrics and Gynecology, Vanderbilt University, Nashville, TN Center for Biostatistics in AIDS Research and Department of Epidemiology, Harvard School of Public Health, Boston, MA Department of Pediatrics, University of Miami Miller School of Medicine, Miami, FL Maternal and Pediatric Infectious Disease Branch, Eunice Kennedy Shriver National Institutes of Child Health and Human Development, National Institutes of Health, Bethesda, MD and Department of Obstetrics and Gynecology, Duke University Medical School, Durham, NC
    J Acquir Immune Defic Syndr 64:374-81. 2013
    ..To determine whether maternal use of tenofovir disoproxil fumarate for treatment of HIV in pregnancy predicts fetal and infant growth...
  18. ncbi request reprint Simple Pediatric AIDS Severity Score (PASS): a pediatric severity score for resource-limited settings
    Kunjal Patel
    Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA
    J Acquir Immune Defic Syndr 43:611-7. 2006
    ....
  19. pmc Following young people with perinatal HIV infection from adolescence into adulthood: the protocol for PHACS AMP Up, a prospective cohort study
    Katherine Tassiopoulos
    Department of Epidemiology, Harvard T H Chan School of Public Health, Boston, Massachusetts, USA
    BMJ Open 6:e011396. 2016
    ..We report the protocol for Pediatric HIV/AIDS Cohort Study (PHACS) Adolescent Master Protocol (AMP) Up, a prospective cohort study enrolling young adult participants for long-term follow-up...
  20. pmc Immunodeficiency in children starting antiretroviral therapy in low-, middle-, and high-income countries
    Manuel Koller
    Institute of Social and Preventive Medicine ISPM, University of Bern, Bern, Switzerland Department of Epidemiology, Harvard School of Public Health, Boston, MA Centre for Infectious Disease Research in Zambia, Lusaka, Zambia Department of Medicine, Indiana University School of Medicine, Indianapolis, IN Department of Pediatrics, Gabriel Toure Hospital, Bamako, Mali Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand Newlands Clinic, Harare, Zimbabwe Maternal and Pediatric Infectious Disease Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development NICHD, Bethesda, MD Department of Pediatrics, College of Health Sciences, Moi University, Kenya INSERM, French National Institute for Health and Medical Research, U897, Bordeaux, France Children s Hospital 1, Ho Chi Minh City, Vietnam and School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa
    J Acquir Immune Defic Syndr 68:62-72. 2015
    ..We describe trends and determinants of CD4 measures at cART initiation in children from low-, middle-, and high-income countries...